Literature DB >> 1249866

Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder.

J F Kelly, M E Snell.   

Abstract

The distribution of hematoporphyrin derivative has been studied in patients undergoing transurethral resections and total cystectomy for carcinoma of the bladder. Although hematoporphyrin derivative fluorescence was not confined to malignant tissues with the dose used there was preferential localization in malignant and pre-malignant epithelium. Also high intensity illumination of an area of hematoporphyrin derivative sensitized carcinoma caused tumor destruction. Therefore, it is suggested that hematoporphyrin derivative could be used as an aid to the diagnosis and treatment of carcinoma of the bladder.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1249866     DOI： 10.1016/s0022-5347(17)59108-9

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


  45 in total

1.  Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects.

Authors:  Eleonora Reginato; Peter Wolf; Michael R Hamblin
Journal:  World J Immunol       Date:  2014-03-27

2.  Evaluation of firefly luciferase bioluminescence mediated photodynamic toxicity in cancer cells.

Authors:  Meike L Schipper; Manishkumar R Patel; Sanjiv S Gambhir
Journal:  Mol Imaging Biol       Date:  2006 Jul-Aug       Impact factor: 3.488

3.  Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.

Authors:  Reema Railkar; L Spencer Krane; Q Quentin Li; Thomas Sanford; Mohammad Rashid Siddiqui; Diana Haines; Srinivas Vourganti; Sam J Brancato; Peter L Choyke; Hisataka Kobayashi; Piyush K Agarwal
Journal:  Mol Cancer Ther       Date:  2017-06-15       Impact factor: 6.261

Review 4.  Photodynamic therapy: a review.

Authors:  J S McCaughan
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

5.  Advanced smart-photosensitizers for more effective cancer treatment.

Authors:  Wooram Park; Soojeong Cho; Jieun Han; Heejun Shin; Kun Na; Byeongdu Lee; Dong-Hyun Kim
Journal:  Biomater Sci       Date:  2017-12-19       Impact factor: 6.843

Review 6.  Photodynamic therapy of cancer: an update.

Authors:  Patrizia Agostinis; Kristian Berg; Keith A Cengel; Thomas H Foster; Albert W Girotti; Sandra O Gollnick; Stephen M Hahn; Michael R Hamblin; Asta Juzeniene; David Kessel; Mladen Korbelik; Johan Moan; Pawel Mroz; Dominika Nowis; Jacques Piette; Brian C Wilson; Jakub Golab
Journal:  CA Cancer J Clin       Date:  2011-05-26       Impact factor: 508.702

7.  Nanoscale Metal-Organic Frameworks for Phototherapy of Cancer.

Authors:  Guangxu Lan; Kaiyuan Ni; Wenbin Lin
Journal:  Coord Chem Rev       Date:  2017-10-21       Impact factor: 22.315

8.  Observations in studies of quantitative kinetics of tritium labelled hematoporphyrin derivatives (HpDI and HpDII) in the normal and neoplastic rat brain model.

Authors:  F M Little; C J Gomer; S Hyman; M L Apuzzo
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

Review 9.  Use of Cyclodextrins in Anticancer Photodynamic Therapy Treatment.

Authors:  Amina Ben Mihoub; Ludivine Larue; Albert Moussaron; Zahraa Youssef; Ludovic Colombeau; Francis Baros; Céline Frochot; Régis Vanderesse; Samir Acherar
Journal:  Molecules       Date:  2018-08-02       Impact factor: 4.411

10.  Photodynamic Therapy for Cancer and for Infections: What Is the Difference?

Authors:  Sulbha K Sharma; Pawel Mroz; Tianhong Dai; Ying-Ying Huang; Tyler G St Denis; Michael R Hamblin
Journal:  Isr J Chem       Date:  2012-09       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.